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Aqueous methanol extract of the tuber of Icacina trichantha was prepared using cold maceration and dried in vacuo at 40°C.  
The extract was purified using solvent-solvent partitioning with n-hexane, dichloromethane, ethyl acetate, n-butanol.  
n-Hexane fraction was purified using Vacuum Liquid Chromatography, eluting with a gradient of dichloromethane in 
methanol (9:1, 7:3, 5:5, 0:10, each 500 mL) to obtain four sub-fractions. Acute toxicity study was done using Lorke’s 
method while in vivo anti-malarial study was carried out using suppressive model. Phytochemical analysis was carried out 
using standard procedure and most active sub-fraction was subjected to gas chromatography-mass spectroscopy. The extract 
at doses of 100, 200 and 400 mg/kg caused a significant (p<0.001) increase in percentage suppression of Plasmodium:  
91.54 %, 94.48 % and 94.58% respectively. Phytochemical analysis of the extract revealed the presence of alkaloids, 
tannins, flavonoids saponin, glycoside, terpenoids, phenols, steroids, carbohydrates, reducing sugars. The GC-MS analysis 
showed the presence of eighteen compounds, the most abundant compound includes 9- octadecenoic acid (Z)-, methyl ester 
(oleic acid, 15.30%), 9, 12-octadecadienoic acid (Z, Z), methyl ester (linoleic acid, 14.34%). These findings suggest 
scientific evidence in support to the use of I. trichantha tuber for the management of malaria.  
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Malaria is well known as a major universal health 
problem, affecting a large population of the world 
especially in African countries1. Malaria is caused by 
the parasitic protozoan Plasmodium falciparum and 
other species including vivax, ovale and malariae. 
The mosquito which acts as vector is the female 
Anopheles funestus, A. mou-cheti, A. gambiae,  
A. arabiensis in mammals and Plasmodium berghei 
cause malaria in rodents especially white albino 
mouse2. Malaria causes human mortality and 
morbidity with a lot of emotional, medical and 
economic impact in the world3. 
In 2011, 106 countries were at risk of transmission 
of malaria and approximately 200 million malaria 
cases were reported in 2012, there were 445,000 
deaths and 216 million cases globally in 20164. 
Pathology of malaria includes anaemia5, 
thrombocytopenia6, acute respiratory distress 
syndrome7. Drugs used in treatment of malaria 
include quinine, chloroquine, hydroxychloroquine, 
amodiaquine, pyronaridine, piperaquine, primaquine, 
artemisinin, artesunate, artemether, arteether, 
dihydroartemisinin etc8. P. falciparum is highly 
resistant to current antimalarial drugs, and majority of 
antimalarial drugs have various side effects and 
problems with patient compliance. Hence, there is need 
for the search for a better, well tolerated and effective 
antimalarial drugs in most malaria endemic areas9,10. 
Icacina trichantha Oliv. (Icacinaceae) is commonly 
found in the rain forest region and jungle vegetation 
of southern Nigeria especially Delta, Edo, Ibadan, 
Akwa ibom and Enugu State. It is a perennial shrub 
with scandent growth above with a very large tuber. 
The Igbos call it ibugo, ji-muo and the yourbas call it 
gbegbe (meaning carry away)11. The leaves are used 
by the Yorubas for coronating their chiefs called 
‘Obas’12. I. trichantha tuber is extensively used 
traditionally in treatment of malaria13, poisoning14, 
hepatitis, constipation, induce emesis, rheumatism, 
toothache and treat soft tumors15. Badeku and Jago 
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villages of Akinyele L.G.A Ibadan, Oyo State South 
West Nigeria use the crushed leaves and tuber 
macerated in local gin to treat malaria. In Ikot 
Ekpene, Essien Udim, Etim Ekpo, Udung Uko, Ibeno, 
Itu, Okobo, Uruan, Oron and Ini L.G.A of Akwa 
Ibom state use the plant in treatment of rheumatism, 
toothache, abortificent, purgative16. It has been 
reported to show significant antimicrobial and 
antioxidant activity16, anti-inflammatory activity17, 
antidiabetic activity18, analgesic effect and 
antinephrotic, antihepatotoxic and emetic activity19, 
antinociceptive activity20, uterine contractile 
activity21. The study aimed at determination of 
phytoconstituents and evaluating the antimalarial 
activity of methanol extracts and fractions of  






Collection and preparation of plant materials 
Sample of I. trichantha tuber was collected from 
Orba, Nsukka, Enugu State Nigeria in March, 2018 by 
Mr. Felix Nwafor, a taxonomist with the Department 
of Pharmacognosy and Environmental Medicine of 
the University of Nigeria, Nsukka, who also identified 
and authenticated the plant. The voucher specimen: 
(PCG/UNN/0015) was deposited at herbarium of the 
above department. The tuber was cleaned and dried in 
the shade till it was brittle in nature. The dried plant 
samples were pulverized with an electric blender and 
stored in amber-coloured bottles prior to extraction. 
 
Extraction of plant material 
A certain quantity (1961 g) of the powdered sample 
was exhaustively extracted with several portions 
(17,500 mL) of 95% methanol in distilled water by 
cold maceration for 72 h with frequent agitation and 
changing the solvent occasionally. The mixture was 
filtered using muslin and Whatman filters paper no.  
1 (Whatman, England). The residue was reextracted 
for another 72 h twice and filtered. The I. trichantha 
extract (ITE) were dried in vacuo at 40ºC. The  
semi-solid extract was weighed and kept at – 200C  
until use.  
 
Solvent fractionation of crude extract 
A certain quantity (100 g) of the methanol crude 
extract of the tuber was dispersed in 50 mL of  
50% methanol and 200 mL of distilled water  
and successively partitioned with n-hexane, 
dichloromethane, ethyl acetate and n-butanol. First, 
about 250 mL of n-hexane was poured into a 
separatory funnel and agitated by shaking well. The 
hexane fraction (HF) was removed by opening the tap 
and collecting the mixtures separately into another 
beaker. This process was repeated until the HF was 
completely extracted to get I. trichanthan-hexane 
fraction (ITHF) (500 mL of n-hexane was used). 
Then, 250 mL of dichloromethane was added to the 
residuals in the separatory funnel and shaken well. 
The dichloromethane fraction (DCF) was removed by 
opening the tap and collecting the mixtures separately 
into a separate beaker and the process repeated  
until all the I. trichantha dichloromethane fraction  
(ITDF) was completely extracted (1000 mL 
dichloromethane was used). To the remaining bulk 
solution, 250 mL of ethylacetate was added to the 
separatory funnel and shaken well. The ethylacetate 
fraction (EAF) was removed by opening the tap and 
collecting the mixtures separately into a separate 
beaker and this process was repeated until the  
I. trichantha ethylacetate fraction (ITEF) was 
completely extracted (2500 mL of ethylacetate was 
used). Finally, equal volume of distilled water was 
added to the extract before 250 mL of n-butanol was 
added into the separatory funnel which was shaken. 
The n-butanol fraction (BF) was removed by opening 
the tap and collecting the mixtures separately into a 
separate beaker and the process was repeated until the 
I. trichantha water fraction (ITWF) and n-butanol 
fractions (ITBF) were completed extracted (2000 ml 
of n-butanol was used). The n-butanol fraction was 
collected separately from the water fraction (WF). 
HF, DCMF, EF and water fractions were dried in 
vacuo at 40ºC. BF with the boiling point of 118ºC was 
mixed with 50 mL of water (100ºC) to form 
azeotropic mixture which boils below the boiling 
point of water was used to concentrate the butanol 
fraction. The fractions were preserved in a refrigerator 
at 4ºC until required for experiment. The percentage 
yield of both the crude, fractions and sub fraction of  
I. trichantha tuber extract was also determined from 
the formula below;  
 
                                
                 
                                
  




                                 
 
                  
                         
  
    
 
 




                                     
 
                      
                           
  




Vacuum Liquid Chromatography (VLC) 
About 2.5 g of n-hexane fraction was dissolved in 
50 mL of absolute methanol and titurated with 50 g of 
silica gel to get a uniform mesh sample. Then the 
glass column (diameter = 4 cm; length= 150 cm) was 
packed to two-third with silica gel 100 cm height 
(100-200 mesh, 500 g: 5699A). For the purpose of 
this study, solid loading was used. In solid loading of 
the sample the uniform mesh sample was introduced 
on the surface of the already well packed adsorbent, 
which was purified by VLC, using silica gel and 
eluted with gradient of dichloromethane (DCM) in 
methanol with different ratios (9:1, 7:3, 5:5, 0:10;  
500 mL each) to afford respective sub fractions coded 
as n-HSF1, n-HSF2, n-HSF3 and n-HSF4 respectively.  
A moderate vacuum from 20-70 mmHg was used to 
prevent loss of solvent due to evaporation. The 
various sub fractions eluted from the VLC were dried 
at 40ºC and reduced pressure and weighed. The sub 
fractions were used further for animal studies to 
screen for the suppressive activity in mouse. 
 
Qualitative phytochemical screening of the extracts and 
fractions 
Phytochemical screening was done using standard 
procedure as described by Trease and Evans22. The 
methanol extract of Icacina trichantha were screened 
for alkaloids, glycosides, saponin, tannins, terpenoids, 
steroids, phenols, flavonoids and carbohydrates. 
 
Acute toxicity studies 
The acute toxicity parameter (LD50) of the extract 
was determined using Lorke’s method23. This method 
involves two steps and a total of thirteen experimental 
animals were used. The first step involved the use of 
nine mice. The nine mice were divided into three 
groups of three animals per group and administered 
per oral (p.o.) 10 mg/kg, 100 mg/kg and 1000 mg/kg 
of methanol extract respectively. Based on the results 
obtained from the first stage, the remaining animals 
were grouped into four groups and the second step 
involved one mouse in each group and specific doses 
(200 mg/kg, 400 mg/kg, 800 mg/kg, 1600 mg/kg) 
were administered. The mice were observed for 24 h 
and deaths were recorded in each case. 
The LD50 for the crude extract were calculated 
using the formula: 
LD50=
                                           
In vivo antimalarial tests 
 
Experimental animals 
Albino mice (6-8 weeks and weight 10.2 - 23.2 g) 
were procured from the Department of Veterinary 
Medicine, Faculty of Veterinary Medicine, University 
of Nigeria, Nsukka. The mice were allowed to 
acclimatize for 7 days at the experimental site. They 
were housed in metallic cages at room temperature of 
22±3ºC, relative humidity of 40–50% and 12 h light/ 
12 h dark cycle. They were allowed access to feed, 
with standard pellets (Grand Cereals Ltd, Enugu 
Nigeria) and water ad libitum. In vivo antimalarial 
study on Albino mice was in compliance with the 
approved protocols (FPSRE/UNN/21/00011) of the 
University of Nigeria Faculty Research Ethics 
Committee on the National Code of Conduct for 
Animal Research Ethics (NCARE)24. 
 
Parasitological studies 
The parasitological study was done in vivo for the 
crude extract, fractions and sub fractions. 
 
Plasmodium preparation and parasite innoculation 
Plasmodium berghei was collected from the 
Department of Parasitology, Faculty of Veterinary 
Medicine, University of Nigeria, Nsukka. Blood from 
the donor mice at peak parasitemia was used. Blood 
was collected from the tail of the donor mouse and 
collected into a heparinized syringes. This was diluted 
serially in phosphate buffered saline (PBS) to make a 
suspension that contains 1×107 infected red blood cell 
(RBC) in every 0.2 mL suspension. Mice were 
innoculated intraperitoneally with 0.2 mL blood 
suspension containing 1×107 parasitized erythrocytes 
on day 0 and were monitored for 3 h before treatment.  
 
Grouping and dosing of animal 
The animals were grouped into 15 groups of 5 mice 
each.  
Group 1: infected with 0.2 mL P. berghei and treated 
with 100 mg/kg of ITE. 
Group 2: infected with 0.2 mL P. berghei and treated 
with 200 mg/kg of ITE. 
Group 3: infected with 0.2 mL P. berghei and treated 
with 400 mg/kg of ITE. 
Group 4: infected with 0.2 mL P. berghei and treated 
with 200 mg/kg of ITHF.  
Group 5: infected with 0.2 mL P. berghei and treated 
with 200 mg/kg of ITDF. 
Group 6: infected with 0.2 mL P. berghei and treated 
with 200 mg/kg of ITEF. 
Group 7: infected with 0.2 mL P. berghei and treated 
with 200 mg/kg of ITBF. 




Group 8: infected with 0.2 mL P. berghei and treated 
with 200 mg/kg of ITWF. 
Group 9: infected with P. bergheiand treated with  
200 mg/kg of n-HSF1. 
Group 10: infected with P. berghei and treated with 
200 mg/kg of n-HSF2. 
Group 11: infected with P. berghei and treated with 
200 mg/kg of n-HSF3. 
Group 12: infected with P. berghei and treated with 
200 mg/kg of n-HSF4. 
Group 13: infected with 0.2 mL P. berghei and treated 
with 7 mg/kg of Arthemether/lumefantrine. (Standard 
antimalarial drug) 
Group 14: positive control, infected with 0.2 mL  
P. berghei but not treated. 
Group 15: negative control not infected with  
P. berghei and not treated. (10% Tween 80) 
Doses were selected based on acute toxicity 
studies. 
 
The 4 day suppressive test 
The infected mice were administered orally 10% 
v/v tween 80, extract (100, 200 and 400 mg/kg), 
fractions and subfractions (200 mg/kg) and 
Arthemether/Lumefantrine 7 mg/kg, respectively.  
The antiplasmodial activity of I. trichantha  
was evaluated using seventy-five (75) P. berghei 
infected mice according to the method described by 
Peter et al.,25. The percentage parasitemia and 
suppression were determined using this formula;  
 
Percentage Parasitemia (%) =
                        
                  
× 100 
 
% suppression (%) = 
                                                                      




Determination of effect of Icacina trichantha on survival time 
of mice 
The survival time of the mice was calculated for  
28 days, immediately after treatment as day 1 till the 
next 28 days. This is done to ascertain the survival 
rate of the mice after treatment is given. After the 
mean survival time was checked, the mice were 
sacrificed using chloroform anesthesia. 
 
Mean survival time MST (days) = ∑x÷x  
 
Where: ∑x=Summation of the number of days the 
individual mice survived in a group. 
 
x= Total number of mice in a group. 
Determination of effect of Icacina trichantha on body weight 
of mice 
The weights of the animals were taken under 
standard conditions. These weights were taken before 
infection (day 0) and on day 4 (when treatment had 
stopped).  
 
Determination of effect of Icacina trichantha on rectal 
temperature of mice 
The rectal temperature of the animals was taken 
before infection; four hours after infection, during 
treatment and after treatment had stopped for five 
days. This was carried out to know the antimalarial 
effect of the plant on increased rectal temperature of 
the diseased mice. 
 
Determination of effect of Icacina trichantha on packed cell 
volume (PCV) of mice 
Packed cell volume (PCV) was estimated as 
described by Ochei and Kolhatkar26. PCV was 
measured to predict the effectiveness of the test 
extract in preventing hemolysis resulting from 
increasing parasitemia associated with malaria. 
 
PCV (%) = 
                       
                         
 
 
Gas Chromatography-Mass Spectroscopy (GC-MS) analysis  
The most potential bioactive non polar subfraction 
of n-hexane of Icacina trichantha (n-HSF2), was 
accurately weighed to 8 mg and was dissolved in 
dichloromethane as the solvent. GC-MS experiment 
was done using standard procedure27. 
 
Statistical analysis 
Data were analyzed using Graph pad prism version 
5.0 and the results presented as mean ± standard error 
of mean (SEM) and “n” represents the number of 
animals per group. One-way analysis of variance 
(ANOVA) followed by Dunnet multiple comparism 
post-hoc test. p˂0.05, p˂0.01 and p˂0.001 were 





The solvents used in this study are all of analytical 
grades and they include: methanol (JHD UN1230, 
China), dichloromethane (JHD UN1593, China), 
ethylacetate (JHD UN1173, China), n-Hexane (JHD 
UN1208, China), n-Butanol and distilled water. 
 
Equipment and instruments 
Equipment and instruments used for this study 
were obtained from the laboratory units of the 
Department of Pharmaceutical and Medicinal 




Chemistry, Department of Veterinary Medicine, 
University of Nigeria, Nsukka and Shimadzu Training 
Centre for Analytical Instruments (STC) Lagos.  
They include: whatman filter paper no 1 (Whatman, 
England), electronic weighing balance (PEC 
MEDICAL, USA), water bath (DK420 Helmreasinn, 
Germany), micro hematocrit centrifuge (Model SH120-
1, England), thermometer (Kris-Aloy International Co., 
Nigeria), rotary evaporator (Model 349/2, Corning Ltd, 
England), Refrigerator (Haier thermocool, England), 
Spectrophotometer (Jeol 400 MHz, Strathclyde 
Scotland), micro – pipettes (Perfect, USA), microscope 
(XSZ – 107BN, India), counting chamber (MC Qiujing, 
China), GCMS-QP2010SE (Shimadzu, Japan).  
 
Reagents and chemicals used for phytochemical analysis 
Sulphuric acid (H2SO4), chloroform (CHCl3), sodium 
hydroxide (NaOH), acetic anhydride (CH3CO)2O, 
glacial acetic acid, iron (III) chloride (FeCl3), Fehling 
solutions A and B, Mayer’s reagent, Dragendoff reagent, 
Wagner’s reagent, Hagers reagent, silica gel (100-200 




Qualitative phytochemical analysis 
The qualitative phytochemical analysis of ITE of  
I. trichantha tuber revealed the presence of alkaloids, 
tannins, saponins, glycosides, flavonoids, steroids, 
terpenoids, phenols, carbohydrates, reducing /free 
sugar and bound sugar (Table 1). The result also 
showed that n-hexane fractions contained alkaloids, 




The data from the antimalarial study (Table 2) 
revealed that the extract (ITE) produced a significant 
(p<0.001) suppression of parasitemia in the infected 
mice in a dose dependent manner. All the fractions 
produced significant (p<0.001) suppression of 
parasitemia. WF produced the highest parasitemia 
suppression (90.44%) followed by n-HF (87.13%), 
EAF (78.92%) and n-BF (66.18%). All the 
subfractions (n-HSF1 to n-HSF4) also produced 
significant suppression of the parasite (p<0.001) in 
the range of 90.00 to 76.47% with the n-HSF2 
showing the highest effect (90.00%). 
 
Mean Survival Time (MST) 
The MST result showed that the fraction n-HF 
(24.00±1.33⃰) significantly (p<0.05) prolonged the 
mean survival time of the infected mice (Table 2). 
The subfraction n-HSF2 also exhibited moderate 
prolongation of the survival time when compared to 
the standard drug ACT. 
 
Body weight and rectal temperature 
The fractions n-HF and WF revealed an increase in 
body weight while the subfraction n-HSF2 and  
n-HSF3 significantly increase (p<0.05) in body weight 
(Table 3). The rectal temperature results shows that 
the subfraction n-HSF2 and n-HSF4 gives a significant 
decrease in rectal temperature (p<0.001). 
 
Packed Cell Volume (PCV) 
Results of PCV (Table 4) showed that the PCV of the 
mice was lowered on day 4 at the dose of 100 and 200 
mg/kg. The plant extract however produced a significant 
improvement in the PCV of the mice at 400 mg/kg. 
 
GC-MS analysis 
The GC-MS analysis (Table 5) showed predominantly 
the presence of eighteen (18) phytochemical 
compounds from the non-polar extract I. trichantha. 
From the results we have different classes of 
Table 1 — Qualitative phytoconstituents of Icacina trichantha extract, its fractions and sub fractions 
Phytoconstituent MCE n-HF DCMF ETF n-BF WF nHSF1 nHSF2 nHSF3 nHSF4 
Alkaloids + + + + + + + + + + 
Tannins + - + + + + - - - - 
Flavonoids + - + + + + - - - - 
Saponin + + + + + + - + + + 
Terpenoids + + + + - - + + + - 
Glycosides + + + + + + + + + + 
Phenols + - + + + + - - - - 
Steroids + + + + - - + + + - 
Carbohydrates + + + + + + - + + + 
Reducing sugar + + + + + + - + + + 
Key: += Present, - = Absent. MCE=Methanolic crude extract, n-HF= n-Hexane fraction, DCMF= Dichloromethane fraction, ETF= 
Ethylacetate fraction, n-BF= n-Butanol fraction, WF= Water fraction , n-HSF1= n-Hexane subfraction DCM: MeOH (9:1), n-HSF2= n-
Hexane subfraction DCM: MeOH(7:3), n-HSF3=n-Hexane subfraction DCM: MeOH (5:5), n-HSF4=n-Hexane subfraction 
MeOH(100%). 
 




compounds which include: fourteen esters (14), one 
alcohol (1), one amide (1), one saturated fatty acid (1) 
and one acyclic alkane (1). 
 
Discussion 
Icacina trichantha (Icacinaceae) tuber extract is 
used in folk medicine as antioxidant16, analgesic, anti-
inflammatory17, antidiabetic18, emetic, antinephrotoxic, 
antihepatoxic19, aphrodisiac and in management of 
poisoning and constipation19. From the antimalarial 
studies, result have shown that I. trichantha  
(tuber) possess a significant antimalarial activity.  
This observation together with the result of the  
present study seems to validate the  traditional  use  of  
Table 2 — Effect of the extract and fractions of I. trichantha on the parasitemia level and mean survival time of mice  
using suppressive model 




Mean Survival Time 
(Days) 
ITE  100 5.75±0.75 ⃰ ⃰ ⃰ 0.62±0.12 ⃰ ⃰ ⃰ 91.54 11.50±0.65 
ITE  200 3.75±0.75 ⃰ ⃰ ⃰ 0.36±0.08 ⃰ ⃰ ⃰ 94.48 14.25±1.49 
ITE  400 3.68±1.20 ⃰ ⃰ ⃰ 0.34±0.11 ⃰ ⃰ ⃰ 94.58 19.33±0.88 
n-HF  200 8.75±2.14 ⃰ ⃰ ⃰ 0.84±0.19 ⃰ ⃰ ⃰ 87.13 24.00±1.33  ⃰
EAF  200 14.33±5.36 ⃰ ⃰ ⃰ 1.49±0.58 ⃰ ⃰ ⃰ 78.92 15.00±2.00 
n-BF  200 23.00±5.57 ⃰ ⃰ ⃰ 2.62±0.70 ⃰ ⃰ ⃰ 66.18 19.67±1.76 
WF  200 6.50±0.87 ⃰ ⃰ ⃰ 0.70±0.10 ⃰ ⃰ ⃰ 90.44 17.00±1.96 
n-HSF1 200 14.00±1.87 ⃰ ⃰ ⃰ 1.51±0.26 ⃰ ⃰ 79.41 18.20±1.96 
n-HSF2 200 6.80±0.97 ⃰ ⃰ ⃰ 0.81±0.16 ⃰ ⃰ ⃰ 90.00 22.00±1.52 
n-HSF3 200 16.00±0.27 ⃰ ⃰ ⃰ 1.89±0.30 ⃰ ⃰ ⃰ 76.47 19.75±1.65 
n-HSF4 200 14.25±3.12 ⃰ ⃰ ⃰ 1.63±0.34 ⃰ ⃰ 79.04 17.00±2.94 
ACT  7 3.20±0.73 ⃰ ⃰ ⃰ 0.32± 0.08 ⃰ ⃰ 95.29 24.60±1.33  ⃰
Normal  - - - 26.00±0.95 ⃰ ⃰ 
Control  68.00±3.11 10.71±0.63 0.00 19.00±1.87 
Results are expressed as Mean ± SEM (n=5), ⃰ p<0.05, ⃰ ⃰ p<0.01, ⃰ ⃰ ⃰ p<0.001, HF= n-Hexane fraction, EAF= Ethyl acetate fraction, BF= 
Butanol fraction, WF= Water fraction, n-HSF1= 9:1 DCM: MEOH n-Hexane sub fraction, n-HSF2= 7:3 DCM: MEOH n-Hexane sub 
fraction, n-HSF3= 5:5 DCM: MEOH n-Hexane sub fraction, n-HSF4= 100% MEOH n-Hexane sub fraction, ACT= Artemether/ 
Lumefantrine, Control= Parasitized with Plasmodium berghei but not treated, Normal= Not Parasited and not treated. 
 
Table 3 — Body weight and rectal temperature of mice treated with methanolic extract, fractions and sub fractions of  
Icacina trichantha tuber 
Body weight (g) Rectal Temperature (ºC)  
Treatment  Dose  
(mg/kg) 
Day 0 Day 4 Percentage Change 
(%) 
Day 0 Day 4 Percentage 
Change (%) 
ITE 100 16.28±0.77 17.25±1.40 5.96 36.28±0.25 35.75±0.38  ⃰ -1.46 
ITE 200 15.12±1.17 14.95±0.95 -1.12 35.36±0.43 35.25±0.39  ⃰ -0.31 
ITE 400 17.06±1.52 15.73±1.12 -7.80 36.06±0.41 36.47±1.17 1.14 
n-HF 200 14.72±0.57 16.70±0.60 13.45 35.90±6.46 36.53±0.51 1.75 
EAF 200 19.32±1.48 18.60±0.99 -3.73 36.26±0.53 35.77±0.32 -1.35 
n-BF 200 15.60±1.37 15.60±2.08 0.00 35.62±1.12 37.13±0.54 4.24 
WF  200 15.28±1.63 16.15±1.87 5.69 35.80±0.77 36.03±0.69 0.64 
n-HSF1  200 17.44±0.66 18.64±0.62 6.88 35.62±0.32  ⃰ 36.02±0.28  ⃰ 1.12 
n-HSF2  200 18.56±0.69 19.42±0.74  ⃰ 4.63 35.50±0.58  ⃰ 35.46±0.44 ⃰ ⃰ -0.11 
n-HSF3  200 18.92±1.04 19.90±1.46  ⃰ 5.18 35.34±0.32  ⃰ 35.88±0.39  ⃰ 1.53 
n-HSF4  200 17.72±0.75 18.60±1.02 4.97 35.86±0.36 35.50±0.26 ⃰ ⃰ ⃰ -1.00 
ACT  7 19.56±1.45 18.70±1.34 -4.40 37.46±0.51 35.88±0.58 ⃰ -4.22 
Normal  17.76±1.46 16.52±1.22 -6.98 37.08±0.33 37.18±0.52 0.27 
Control  17.00±1.03 14.85±0.91 -12.65 37.20±0.27 38.00±0.20 2.15 
Results are expressed as Mean ± SEM (n = 5), %change = Day 4 – Day 0 ×100 Day 0 1 
⃰ p<0.05, ⃰ ⃰p<0.01,⃰ ⃰ ⃰ p<0.001, n-HF= n-Hexane fraction, EAF= Ethyl acetate fraction, n-BF=n-Butanol fraction, WF= Water fraction,  
n-HSF1= 9:1 DCM: MEOH n-Hexane sub fraction, nHSF2= 7:3 DCM: MEOH n-Hexane sub fraction, n-HSF3= 5:5 DCM: MEOH  
n-Hexane sub fraction, n-HSF4= 100% MEOH n-Hexane sub fraction, ACT= Artemether/Lumefantrine, Control= Parasitized  
with Plasmodium berghei but not treated, Normal= Not Parasited and not treated. 
 





Table 4 — Effect of Icacina trichantha on packed cell volume (PCV) of mice in a suppressive antimalarial model 
Treatments  Dose 
(mg/kg) 
Packed cell volume (%) 
Day 0 Day 4 % Change 
ITE  100 41.20±0.86 34.00±3.19 -17.48 
ITE  200 41.00±0.63 38.50±1.71 ⃰ ⃰ -6.10 
ITE  400 38.60±0.98 39.00±2.52 ⃰ ⃰ 1.04 
ACT  7.0 40.00±0.71 40.00±0.84  ⃰ 0.00 
Control  39.20±0.86 27.75±1.44 -29.21 
Results are expressed as Mean ± SEM (n =5), ⃰ p<0.05, ⃰ ⃰p<0.01,⃰ ⃰ ⃰ p<0.001, not significant at p>0.05, 100 mg/kg, 200 mg/kg and 400 
mg/kg shows the dose of the methanol extract, ACT= Artemether/ Lumefantrine, Control= Parasitized with Plasmodium berghei but not 
treated, Normal= Not Parasitized and not treated 
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I. trichantha in treatment of malaria. The in vivo 
model was used to check the involvement of the 
immune system in combating the infection28. 
The toxicity test (LD50) showed that the tuber of 
the plant is relatively safe at a dose of 1265 mg/kg.  
high LD50 obtained for any extract indicates that the 
extract and  fraction  is  relatively  safe29.  Among  the 
fractions, water fractions, n-hexane and ethylacetate 
were found to possess higher antiplasmodial 
potentials, suggesting the possible localization  
of the active ingredient in these fractions. Similar 
observations have been reported in previous studies30. 
Antimalarial treatment with a known compound like 
artemisinin is associated with a rapid decline in 
parasitemia31.  
The mean survival time of the various groups that 
were administered with the fractions relative to the 
control also helped prove the antimalarial efficacy of 
the plant. This could be due to suppression of the 
parasite from multiplying in the bloodstream.  
Measurement of packed cell volume (PCV) was 
done to evaluate the effectiveness of the methanol 




extract in preventing hemolysis due to increasing 
parasitemia level. Blood was used as a diagnostic tool 
in this study because it is used as a good indices in 
assessment of haematological parameters32,33. The low 
PCV value observed in 100 and 200 mg/kg of ITE 
with a corresponding high number of parasite was 
suggested to be due to excessive destruction of red 
blood cell by the parasite which could lead to anaemia 
if left untreated and this suggest that the extract at low 
doses where not able to prevent hemolysis of the 
RBC. As observed in this study, it was established 
that the more malaria parasite is in the blood 
circulation it will cause severe destruction of the red 
blood cell as demonstrated by the low PCV. The 
significant reduction in PCV level indicates a 
relationship between malaria parasite and anemia34. 
From the study, we could suggest that the potential 
mechanisms contributing to malaria is multifactorial, 
there is lysis of parasitized erythrocytes, inadequate 
reticulocyte production, dyserythroporetic changes, 
immune mediated haemolysis, phagocytosis, splenic 
sequestration, bone marrow suppression, effects of 
inflammatory cytokines, effects of parasite factors and 
reduction in the lifespan of the erythrocytes17,35. The 
lysis of parasitized erythrocytes will inevitably lead to 
black urine, increase in body temperature and loss of 
body weight36. Anemia, body weight loss and fever 
are the general features of malaria infected mice37. 
The increase in body weight of the animals observed 
for the fraction may be due to constant feeding  
of the animals. 
Rectal temperature determination revealed the 
plant have an analgesic effect which has been shown 
in previous studies, the mechanism by which the 
extract inhibits increase in temperature is not yet 
known, but a free radical scavenging activity was 
hypothesized17. 
All the mice used for dichloromethane fraction 
died on the third day of treatment, thus there was no 
result of parasitemia for dichloromethane fraction and 
this could be that at 200 mg/kg dose of the 
dichloromethane fraction was not enough to suppress 
the parasite in the red blood cell. Before the mice died 
it exhibited symptoms such as diarrhea, chills and 
shivering, reduced activity, pallor, poor appetite, 
fever/increased rectal temperature, dark urine. All 
these symptoms showed that the mice have severe 
malaria. The qualitative phytochemical analysis of the 
methanol extract, fractions and sub fraction of  
I. trichantha shows that the plant is rich in 
phytoconstituents. The active compound responsible 
for the antiplasmodial activity is yet to be identified. 
Antiplasmodial potentials of I. trichantha could be 
attributed to a single or a combination of its 
phytoconstituents such as alkaloids, flavonoids, 
terpenoids, steroids, glycosides, tannins, saponins, 
reducing sugars, phenols and carbohydrates (Table 1) 
in high concentrations. The plant owes its medicinal 
properties to these phytoconstituents20. Alkaloids have 
been implicated in antimalarial activity of many 
plants38. Terpenoid, saponin and steroid have also 
been found to be detrimental to several infectious 
protozoans such as P. falciparum39. Tannins are 
phytoconstituents used in treatment of inflamed 
tissues and have been reported to have good potentials 
in malaria suppression40. Flavonoids acts by releasing 
its anion radicals which circulate to tissues and also 
by inhibition of membrane bound enzymes such as 
ATPase and phospholipase A2 thereby serving as a 
health promoter41. Phenols are the most effective 
phytoconstituents in protecting the body against 
different oxidative stressors, phenolic compounds also 
have anticancer, antiplasmodial and antioxidant 
potentials22. Alkaloids have been shown to have 
antiplasmodial potentials by inhibiting the actions of 
plasmodium from lysing the cell membrane42. Jeruto 
et al. 43 have reported that flavonoids, steroids and 
terpenoids have protective effect on RBC due to its 
antioxidant properties. Eighteen (18) bioactive 
compounds were predominantly suggested in the  
sub fraction of n-hexane I. trichantha tuber. Gas 
Chromatography-Mass Spectroscopy analysis of the 
volatile chemical compositions of I. trichantha from 
the sub fraction of n-hexane were highly complex 
containing fatty acids, esters, alcohol, amide, acyclic 
compounds (Table 5). Out of the eighteen compounds 
present in n-HSF2, 9,12-octadecadienoic acid (Z,Z), 
methyl ester (14.34 %), 9- octadecenoic acid (Z)-, 
methyl ester or oleic acid methyl ester (15.30%), 
1,1,6-trimethyl-3-methylene-2-(3,6,9,13-tetramethyl-
6-ethenye-10,14-dimethylene-pentadec-4-enyl) 
cyclohexane (12.88%), 1-heptatriacotanol (8.38%) 
have the highest abundance as shown in their peak 
area. Thus in the present study, it is possible that the 
oleic acid and linoleic acid acts in synergy with other 
identified constituents to exert the antiplasmodial 
activities exhibited by I. trichantha tuber. Most of 
these constituents have been found to show interesting 
biological activities against certain illnesses and 
pathogens, for instance, antibacterial, antioxidant, 




antimicrobial16, antiinflammatory17, cytotoxic, 
anticancer activities have been reported. Saturated 
fatty acids such as oleic acid, a bioactive compound 
have been scientifically reported to have antimalarial 
activity44. In summary, fatty acids could play some 




The methanol extract and fractions of Icacina 
trichantha possess a good antiplasmodial activity. The 
crude, fractions and subfractions of the plant can be 
used for the management of malaria in herbal 
medicine and can lead to development of lead 
compound. There was a reduced parasite burden, 
relative increase in body weight, reduction in rectal 
temperature and this justify the traditional usage of 
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